For instance, GD2-targeted CAR T cells engineered with heparanase (HPSE), an enzyme which degrades HSPGs of the ECM, have been shown to improve infiltration and anti-tumor function in a xenograft mouse model of human neuroblastoma [193]. This evidence concerns the gene HPSE and neoplasm.